Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes

NCT00212290 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

140

Enrollment

NIH

Sponsor class

Conditions

Insulin Resistance
Type 2 Diabetes Mellitus

Interventions

DRUG: pioglitazone
DRUG: nateglinide
DRUG: placebo

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)